Despite close competition from other pressing issues, the economy is still the top concern for voters, according to a new Cheddar/SurveyUSA poll.
The poll, conducted October 1-4, 2020, showed that 15 percent of respondents named the economy as the most important issue for them when marking their presidential ballot.
This perennial election issue squeaked in ahead of "defeating Donald Trump" at 14 percent, compared to "re-electing Donald Trump" at 9 percent. Replacing the president got a two-point boost, however, after his COVID-19 diagnosis, with the economy losing ground as well.
There was also a significant spread in which demographic groups pinpointed the economy as the top issue, with 19 percent of Hispanics, 15 percent of whites, and just 7 percent of Blacks choosing the issue.
Amid nationwide protests and counterprotests, respondents were neatly split on issues of social justice and law and order. Black Lives Matter, social justice, and law and order each received 3 percent while All Lives Matter received 5 percent.
Other top concerns include COVID-19 at 12 percent, healthcare at 9 percent, and "preserving the democracy" at 6 percent.
On the Affordable Care Act — which reemerged as an election-year issue with the passing of Supreme Court Justice Ruth Bader Ginsburg — 54 percent of respondents said the Court should leave it as the law of the land, while 31 percent said it should be declared unconstitutional.
This matches closely with the 56 percent who said they felt either favorably or very favorably toward Obamacare and the 38 percent who felt unfavorably or very unfavorably toward it.
Younger and lower-income voters also had a better impression of the healthcare law — though those who were most concerned with the economy were less likely to be in favor. After Trump's COVID diagnosis, favorable impressions got a boost as well.
Finally, the poll showed significant doubts about the outcome of the 2020 presidential election. Just 28 percent said the country will know the outcome on election day, while 42 percent said: "maybe a week after." A sizable 21 percent predicted we'd know sometime before Thanksgiving.
Again, Trump's hospital visit shifted the numbers, with slightly more believing the election would be over and done with on Election Day.
Jill and Carlo cover the latest on Omicron, another school shooting in America and more. Plus, bidding farewell to 'transitory' inflation, and the controversy surrounding 'Lovely Bones' author Alice Sebold.
Disparities in tree coverage across America is a huge issue that affects air quality, heat exposure, and ultimately determines how resilient communities are against climate change. The Build Back Better Act is allocating $2.5 billion to boost 'tree equity.' Lemir Teron, assistant professor at SUNY College of Environmental Science and Forestry, joins Cheddar News to explain why this is a priority for Democrats today.
The Supreme Court will be hearing arguments in Dobbs v. Jackson Women's Health on Wednesday over a Mississippi law banning abortions after 15 weeks. Jimmy Hoover, the Supreme Court editor-at-large for Law360, joined Cheddar to break down the momentous legal fight. "This is the biggest abortion case at the Supreme Court in 30 years," he said. "It is a … a direct challenge to Roe v. Wade."
Matt Peron, Director of Research at Janus Henderson Investors, joins Cheddar News' Closing Bell, where he breaks down the factors leading to today's market slide and says there's more to it than Fed Chair Jerome Powell's comments about speeding up tapering efforts.
Walmart CEO Dough McMillon praised the Biden administration's efforts to ease supply chain constraints after the company saw a 26 percent jump in shipments over the last month. President Joe Biden had announced back in October that California ports would operate on a 24/7 basis.
Jill and Carlo cover the latest developments with the Omicron variant that are spooking markets once again. Twitter's @Jack is leaving, SCOTUS takes up abortion rights and the world has a brand new republic.
The Biden Administration is set to buy 10 million courses of Pfizer's Covid pill if it gains emergency use authorization from the FDA. With this purchase, the U.S. will receive more than 13 million courses of antiviral pills aimed at treating Covid and reducing severe illness and death. Pfizer's pill has been shown to reduce risk of hospitalization and death by 89 percent, proving it could be a key tool in the fight against the pandemic. Dr. Soumi Eachempati, Co-Founder, CEO & CMO of Cleared4, joined Cheddar News to discuss.
